Bharat Biotech on Thursday said it plans to produce additional 200 million (20 crore) doses of COVID-19 vaccine 'Covaxin' at its subsidiary's Gujarat-based facility, taking the overall production......
India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use......